It is characterized by sustained and substantial reduction of the peripheral lymphocyte counts, mainly CD4-T and CD8-T cells in COVID-19 patients, and is associated with a high risk of developing secondary bacterial infection. The gene discussed is CD4; the disease is COVID-19.